MoonLake requested a Type B meeting with the U.S. Food and Drug Administration (FDA) to obtain regulatory clarity and discuss ...
Abstract: This article proposes a distributed multiagent formation control framework, ensuring rigorous safety and solely relying on range-only measurements. To address the challenge of rigid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback